Advanced melanoma showed reduced class-switched IgG+memory and transitional B cell subsets, enhanced plasmablasts, CD21lo naïve and DN populations, driven by stage IV disease and PD-L1+TGFβ+ naive B cells, driven by stage III (online supplemental figure 3B). The gene discussed is TGFB1; the disease is melanoma.